Assessing the potential for precision medicine in body weight reduction with regard to type 2 diabetes mellitus therapies: A meta‐regression analysis of 120 randomized controlled trials.

MLA

Vargas, Kris G., et al. “Assessing the Potential for Precision Medicine in Body Weight Reduction with Regard to Type 2 Diabetes Mellitus Therapies: A Meta‐regression Analysis of 120 Randomized Controlled Trials.” Diabetes, Obesity & Metabolism, vol. 26, no. 6, June 2024, pp. 2139–46. EBSCOhost, https://doi.org/10.1111/dom.15519.

APA

Vargas, K. G., Rütten, T., Siemes, B., Brockmeyer, M., Parco, C., Hoss, A., Schlesinger, S., Jung, C., Roden, M., Kelm, M., Wolff, G., & Kuss, O. (2024). Assessing the potential for precision medicine in body weight reduction with regard to type 2 diabetes mellitus therapies: A meta‐regression analysis of 120 randomized controlled trials. Diabetes, Obesity & Metabolism, 26(6), 2139–2146. https://doi.org/10.1111/dom.15519

Chicago

Vargas, Kris G., Tobias Rütten, Benedikt Siemes, Maximilian Brockmeyer, Claudio Parco, Alexander Hoss, Sabrina Schlesinger, et al. 2024. “Assessing the Potential for Precision Medicine in Body Weight Reduction with Regard to Type 2 Diabetes Mellitus Therapies: A Meta‐regression Analysis of 120 Randomized Controlled Trials.” Diabetes, Obesity & Metabolism 26 (6): 2139–46. doi:10.1111/dom.15519.